Patents by Inventor Petr Naus

Petr Naus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 7-deazapurine nucleosides for therapeutic uses
    Patent number: 10294262
    Abstract: The invention provides compounds of formula I, wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: May 21, 2019
    Assignee: INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I.
    Inventors: Aurelie Bourderioux, Michal Hocek, Petr Naus
  • NOVEL 7-DEAZAPURINE NUCLEOSIDES FOR THERAPEUTIC USES
    Publication number: 20170240584
    Abstract: The invention provides compounds of formula I, wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Application
    Filed: March 8, 2017
    Publication date: August 24, 2017
    Inventors: Aurelie Bourderioux, Michal Hocek, Petr Naus
  • 7-deazapurine nucleosides for therapeutic uses
    Patent number: 9624257
    Abstract: The invention provides compounds of formula I: wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: April 18, 2017
    Assignee: Institute of Organic Chemistry and Biochemistry of the ASCR, V.V.I.
    Inventors: Aurelie Bourderioux, Michal Hocek, Petr Naus
  • Substituted 7-deazapurine ribonucleosides for therapeutic uses
    Patent number: 9586986
    Abstract: Compounds of Formula I and a pharmaceutically acceptable salt thereof, an optical isomer thereof, or a mixture of optical isomers thereof, as well as compositions which include such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: March 7, 2017
    Assignees: INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I., PALACKY UNIVERSITY IN OLOMOUC
    Inventors: Michal Hocek, Petr Naus, Olga Caletkova, Marian Hajduch, Petr Dzubak
  • NOVEL 7-DEAZAPURINE NUCLEOSIDES FOR THERAPEUTIC USES
    Publication number: 20160318970
    Abstract: The invention provides compounds of formula I: wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Application
    Filed: March 17, 2016
    Publication date: November 3, 2016
    Inventors: Aurelie BOURDERIOUX, Michal Hocek, Petr Naus
  • NOVEL SUBSTITUTED 7-DEAZAPURINE RIBONUCLEOSIDES FOR THERAPEUTIC USES
    Publication number: 20160159844
    Abstract: Compounds of Formula I and a pharmaceutically acceptable salt thereof, an optical isomer thereof, or a mixture of optical isomers thereof, as well as compositions which include such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Application
    Filed: December 5, 2014
    Publication date: June 9, 2016
    Applicants: Institute of Organic Chemistry and Biochemistry ASCR, v.v.i., Palacky University in Olomouc
    Inventors: Michal HOCEK, Petr NAUS, Olga CALETKOVA, Marian HAJDUCH, Petr DZUBAK
  • 7-deazapurine nucleosides for therapeutic uses
    Patent number: 9321800
    Abstract: The invention provides compounds of formula I, wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: April 26, 2016
    Assignee: Gilead Sciences, Inc.
    Inventors: Aurelie Bourderioux, Michal Hocek, Petr Naus
  • NOVEL 7-DEAZAPURINE NUCLEOSIDES FOR THERAPEUTIC USES
    Publication number: 20150218201
    Abstract: The invention provides compounds of formula I, wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 6, 2015
    Applicant: Institute of Organic Chemistry and Biochemistry ASCR, V.V.I.
    Inventors: Aurelie Bourderioux, Michal Hocek, Petr Naus
  • Cytostatic 7-deazapurine nucleosides
    Patent number: 8093226
    Abstract: The invention provides compounds of formula I: wherein R1 and R2 have any of the values defined in the specification and salts thereof, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: January 10, 2012
    Assignee: Institute of Organic Chemistry and Biochemistry of the ASCR, V.V.I.
    Inventors: Michal Hocek, Petr Naus
  • NOVEL CYTOSTATIC 7-DEAZAPURINE NUCLEOSIDES
    Publication number: 20090203637
    Abstract: The invention provides compounds of formula I: wherein R1 and R2 have any of the values defined in the specification and salts thereof, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds.
    Type: Application
    Filed: January 15, 2009
    Publication date: August 13, 2009
    Inventors: Michal Hocek, Petr Naus